FDA Issues Warning Over Injectable CBD in California

The U.S. Food and Drug Administration (FDA) has recently issued a warning letter to a California-based company, Green Wave Ingredients, for selling an injectable form of CBD. This action marks a significant move by the FDA to regulate the burgeoning CBD market, especially concerning products that pose potential health risks.

The product in question, sold under the brand name 'Green Wave Injectable CBD,' was marketed as a treatment for various ailments, including pain and inflammation. The FDA's letter highlighted that the product is considered an unapproved new drug under the Federal Food, Drug, and Cosmetic Act. The agency emphasized that injectable CBD has not been evaluated for safety and efficacy, and its use could lead to serious health consequences.

Green Wave Ingredients, based in Los Angeles, has been ordered to cease the sale and distribution of the injectable CBD immediately. The company must also provide the FDA with a detailed plan on how they intend to address the violations. This incident underscores the ongoing challenges faced by the FDA in overseeing the rapidly growing CBD industry, which has seen a surge in products ranging from oils and edibles to more controversial items like injectables.

The FDA's warning serves as a reminder to consumers to be cautious of unregulated CBD products and to consult healthcare professionals before using any new treatment. As the CBD market continues to evolve, it is likely that regulatory bodies will increase scrutiny to protect public health.

• California
• CBD
• FDA
• Green Wave Ingredients

Detailed

Calif. startup is selling injectable cannabis. The FDA isn't happy.

3 weeks ago

- sfgate